Skip to main content
. 2008 Dec 18;10(Suppl 4):S22. doi: 10.1186/bcr2182

Figure 1.

Figure 1

Example of a phase II study aiming at identifying mechanisms of drug resistance. Presented is an example of a phase II study designed with the primary aim of exploring mechanisms of resistance to epirubicin and paclitaxel; each drug was administered as a monotherapy regimen [33].